Find a solution
Genomic instability is a major problem in cancer progression and therapy resistance. Cytura Therapeutics aims to find a solution to stop destabilization of the genome. By targeting genomic instability both as a stand-alone therapy, as well as in combination therapy, therapy resistance or relapse can be avoided.
This will help make cancer treatment more effective and improve the lives of patients worldwide.